Cancer Treatment Device Maker Beats Antitrust Claims

Law360, Houston (April 26, 2013, 9:13 PM ET) -- A Texas federal judge on Thursday rejected antitrust claims asserted by a medical device maker against unit of Elekta AB, ruling that the lawsuit did not sufficiently establish that the company monopolized the market for a radiation therapy component used to treat cancer.

U.S. District Judge Harry Lee Hudspeth ruled that Oncology Tech Inc. could not pursue claims under the Texas Antitrust Act or the Sherman Antitrust Act against Impac Medical Systems Inc., because analogues to Oncology Tech’s devices are readily available in the allegedly restricted...
To view the full article, register now.